Phase I pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent OXi4503 in patients with advanced solid tumors

Journal article

Peer reviewed

M. Zweifel, D. M. Patterson, A. R. Padhani, M. R. Middleton, P. Price, M. R. Stratford, P. Ross, S. Halford, Z. Goldberg and G. J. Rustin

Journal of clinical oncology, Vol.28(15_suppl), pp.2594-2594

05/20/2010

Abstract

Abstract only

1 Record Views

Title: Phase I pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent OXi4503 in patients with advanced solid tumors
Creators: M. Zweifel
D. M. Patterson
A. R. Padhani
M. R. Middleton
P. Price
M. R. Stratford
P. Ross
S. Halford
Z. Goldberg
G. J. Rustin
Publication Details: Journal of clinical oncology, Vol.28(15_suppl), pp.2594-2594
Identifiers: 991006015762302656
Academic Unit: Pharmacy Practice
Language: English
Resource Type: Journal article